AI Investing
Latest news, explainers and analysis on AI Investing. Tracking 4 stories on Arth Vani.
Connected in the graph
Latest on AI Investing
IPOVantage Markets Launches Unitree Robotics Pre-IPO CFDs for Global Tech Investors
Vantage Markets has expanded its Pre-IPO CFD portfolio by adding Unitree Robotics, allowing eligible traders to speculate on the valuation of the AI-driven robotics firm before its public debut. The new instrument, traded under the symbol UNITREEUSD, aims to capture retail interest in frontier artificial intelligence and humanoid technology.

Young Investors Trust AI More Than Influencers for Financial Advice: UK Study
Younger British investors are increasingly trusting artificial intelligence (AI) tools for investment advice over traditional media and social media influencers, a recent study by the UK's Financial Conduct Authority (FCA) reveals. This shift highlights a growing global trend where digital natives are turning to technology for financial guidance, prompting a re-evaluation of how investment advice is consumed.

Even 'AI Nostradamus' Faces Market Shocks: A Lesson After 73% Investment Drop
A 24-year-old hedge fund prodigy, once called the 'Nostradamus of AI', recently experienced a significant 73% drop in an investment. This incident highlights the inherent volatility and risks in highly speculative sectors like artificial intelligence, even for seemingly expert investors. Indian retail investors should learn from this to approach new technologies with caution, focusing on due diligence and risk management over market hype.

Micron vs SanDisk: Decoding the High-Stakes AI Memory Battle for Investors
As Artificial Intelligence demands faster data processing, semiconductor giants Micron and SanDisk are emerging as key players in the hardware race. This shift offers a strategic roadmap for Indian retail investors looking to capitalize on global tech growth through international stocks and thematic mutual funds.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.